Genmab A/S Files 6-K for December 2024
Ticker: GNMSF · Form: 6-K · Filed: Dec 4, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, registration-statement
TL;DR
Genmab filed a 6-K, nothing major but it's now part of their S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on December 4, 2024, to report information for the month of December 2024. This filing is incorporated by reference into Genmab's existing S-8 registration statements (File Nos. 333-232693, 333-253519, 333-262970, and 333-277273). The company's principal executive offices are located in Valby, Denmark.
Why It Matters
This filing serves as an update for investors and indicates ongoing reporting requirements for Genmab A/S, a significant player in the pharmaceutical industry.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information into existing registration statements, with no new material financial or operational disclosures.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-24-015999 (document_id) — Accession Number
- 20241204 (date) — Filing Date
- 333-232693 (registration_statement_id) — S-8 File Number
- 333-253519 (registration_statement_id) — S-8 File Number
- 333-262970 (registration_statement_id) — S-8 File Number
- 333-277273 (registration_statement_id) — S-8 File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The Form 6-K is filed to report information for the month of December 2024 and is incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
What are the file numbers for Genmab A/S's Form S-8 registration statements mentioned in the filing?
The mentioned Form S-8 registration statements have file numbers 333-232693, 333-253519, 333-262970, and 333-277273.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on December 4, 2024.
Where are Genmab A/S's principal executive offices located?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Does this filing contain new financial results for Genmab A/S?
No, this filing is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 and is incorporated by reference into existing registration statements, rather than presenting new financial results.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-12-04 11:26:24
Filing Documents
- tmb-20241204x6k.htm (6-K) — 19KB
- tmb-20241204xex3d1.htm (EX-3.1) — 279KB
- 0001558370-24-015999.txt ( ) — 299KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF DECEMBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: DECEMBER 4, 2024 EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association